NEW YORK (GenomeWeb News) – Shareholders of Ventana Medical Systems have tendered 25.5 million shares, or 70.5 percent of Ventana’s outstanding stock, as of the close of the tender offer last night.
 
In January, after several months of pursuing Ventana, Roche finally reached an agreement to acquire the tissue-based diagnostics products firm for approximately $3.4 billion, or $89.50 per share. That was up from its previously rejected bid of $75 per share.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.